Insider Trading: Albany Molecular Research Inc (AMRI.O)

AMRI.O on Nasdaq

11.05USD
23 May 2013
Price Change (% chg)

$0.08 (+0.73%)
Prev Close
$10.97
Open
$10.76
Day's High
$11.11
Day's Low
$10.45
Volume
262,655
Avg. Vol
520,283
52-wk High
$12.50
52-wk Low
$2.25

Search Stocks
SARGENT BRUCE J Options Exercised: 0
Trade Date: Monday, 5 Mar 2012 Price: 2.66
Title: Officer Shares Held: 53,676
Type Traded: Direct Net Change in Shares This Filing: -220

Institutional Holders

% Shares Owned: 72.15%
# of Holders: 97
Total Shares Held: 22,668,869
3 Mo. Net Change: 7,577,775
# New Positions: 28
# Closed Positions: 13
# Increased Positions: 61
# Reduced Positions: 30
# Net Buyers: 31

Officers & Directors

Name Age Since Current Position

Thomas D' Ambra

56 2003 Chairman of the Board, President, Chief Executive Officer

Michael Nolan

46 2012 Chief Financial Officer, Vice President, Treasurer

Steven Hagen

51 2012 Senior Vice President - Pharmaceutical Development and Manufacturing

Bruce Sargent

58 Senior Vice President - Drug Discovery

Lori Henderson

50 2011 Vice President, General Counsel, Secretary

Richard Saffee

2013 Vice President and General Manager - Large Scale Manufacturing

Takeshi Yura

2013 Vice President - Discovery and Development Services, Asia

Una Ryan

70 2010 Lead Independent Director

William Marth

57 2012 Director

Veronica Jordan

61 2006 Independent Director

Gabriel Leung

2010 Independent Director

Kevin O' Connor

57 2000 Independent Director

Arthur Roth

72 2003 Independent Director
Search Stocks